Avant Diagnostics is a medical diagnostic technology company that specializes in large panel biomarker screening. It develops phosphoproteomic technologies for measuring the activation state of key drug targets and signaling pathways, with applications across multiple cancer types, including breast, non-small cell lung, colorectal, and pancreatic.